This inventor holds 0 USPTO granted patents, plus 1 CIPO patent.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Title: Agneta Barbro Ekman: Innovator in Therapeutic Compounds
Introduction
Agneta Barbro Ekman is a notable inventor based in Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that are therapeutically useful for treating central nervous system disorders. His innovative work has garnered attention in the scientific community.
Latest Patents
Agneta Barbro Ekman holds a patent for "Halo Substituted Aminotetralins." This invention involves therapeutically useful tetralins and pharmaceutically acceptable acid addition salts. The compounds are characterized by a specific formula that includes various substituents, making them valuable in the treatment of central nervous system disorders. Notably, he currently has 0 patents.
Career Highlights
Throughout his career, Agneta has worked with prominent figures in the pharmaceutical industry. His experience and expertise have allowed him to contribute to significant advancements in therapeutic compounds.
Collaborations
Agneta has collaborated with notable individuals such as Per Arvid Emil Carlsson and Hakan Vilhem Wikstrom. These collaborations have played a crucial role in his research and development efforts.
Conclusion
Agneta Barbro Ekman is a distinguished inventor whose work in therapeutic compounds has the potential to impact the treatment of central nervous system disorders. His innovative contributions continue to be recognized in the field of pharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile